NCT02135042 2026-03-18Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNANRG OncologyPhase 2/3 Active not recruiting685 enrolled
NCT07138989 2025-08-24EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 2 Not yet recruiting10 enrolled